The utility of 5-alpha reductase inhibitors in the prevention and diagnosis of prostate cancer.
about
Targeted therapy in prostate cancer.Zyflamend inhibits the expression and function of androgen receptor and acts synergistically with bicalutimide to inhibit prostate cancer cell growth.Effect of finasteride on serum prostate-specific antigen (PSA) and on prostate of hamster Mesocricetus auratus (hMa).
P2860
The utility of 5-alpha reductase inhibitors in the prevention and diagnosis of prostate cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The utility of 5-alpha reducta ...... diagnosis of prostate cancer.
@en
The utility of 5-alpha reducta ...... diagnosis of prostate cancer.
@nl
type
label
The utility of 5-alpha reducta ...... diagnosis of prostate cancer.
@en
The utility of 5-alpha reducta ...... diagnosis of prostate cancer.
@nl
prefLabel
The utility of 5-alpha reducta ...... diagnosis of prostate cancer.
@en
The utility of 5-alpha reducta ...... diagnosis of prostate cancer.
@nl
P1476
The utility of 5-alpha reducta ...... diagnosis of prostate cancer.
@en
P2093
Amanda Beth Reed
Dipen J Parekh
P304
P356
10.1097/MOU.0B013E328329EB29
P577
2009-05-01T00:00:00Z